MedPath

KETOCONAZOLE

Ketoconazole Tablets, USP200 mgRx Only

Approved
Approval ID

57e81e13-b395-4dbd-b660-3038de41a838

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 1, 2023

Manufacturers
FDA

Burel Pharmaceuticals, LLC

DUNS: 609436204

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ketoconazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code35573-433
Application NumberANDA075912
Product Classification
M
Marketing Category
C73584
G
Generic Name
ketoconazole
Product Specifications
Route of AdministrationORAL
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (5)

KETOCONAZOLEActive
Quantity: 200 mg in 1 1
Code: R9400W927I
Classification: ACTIB
METHYLCELLULOSE (15 CPS)Inactive
Code: NPU9M2E6L8
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KETOCONAZOLE - FDA Drug Approval Details